| Period Ending | 02-Mar-2013 | 03-Mar-2012 | 26-Feb-2011 |
|---|
|
Total Revenue
|
700,224
|
662,463
|
582,777
| | Cost of Revenue | 554,491 | 545,343 | 499,657 | | |
Gross Profit
|
145,733
|
117,120
|
83,120
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 118,314 | 113,304 | 104,092 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
27,419
|
3,816
|
(20,972)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 649 | 1,259 | 858 |
|
Earnings Before Interest And Taxes | 28,068 | 5,075 | (20,114) |
|
Interest Expense | 1,494 | 1,427 | 719 |
|
Income Before Tax | 26,574 | 3,648 | (20,833) |
|
Income Tax Expense | 7,796 | (1,049) | (6,676) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 18,778 | 4,697 | (14,157) | |
|
Non-recurring Events |
|
Discontinued Operations | 333 | (52) | 3,825 |
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
19,111
|
4,645
|
(10,332)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
19,111
|
4,645
|
(10,332)
|
|
2.74%